Clinical Trial Update: Assessing Optimal XR-Buprenorphine Initiation Points in Jail [Phase 4]

View source ↗

Summary

Clinical trial investigating initiation points for XR-Buprenorphine in jail for opioid use disorder was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• XR-Buprenorphine (buprenorphine XR)

Snippet

Sponsor: NYU Langone Health | Conditions: Opioid Use Disorder | Phase 4 | Status: WITHDRAWN